We are live on ! Find out more
GW

GW & Wade Portfolio holdings

AUM $3.08B
1-Year Est. Return 18.99%
This Fund
S&P 500
This Quarter Est. Return
+3.95%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$583M
AUM Growth
+$70.5M
Cap. Flow
+$51.4M
Cap. Flow %
8.81%
Top 10 Hldgs %
36.17%
Holding
250
New
35
Increased
100
Reduced
52
Closed
16

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$6.06M
2
MET icon
MetLife
MET
+$5.53M
3
BA icon
Boeing
BA
+$4.61M
4
EXR icon
Extra Space Storage
EXR
+$4.19M
5
ORCL icon
Oracle
ORCL
+$2.67M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$6.06M
2
ED icon
Consolidated Edison
ED
+$4.43M
3
SYY icon
Sysco
SYY
+$4.28M
4
UL icon
Unilever
UL
+$4.01M
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$1.16M

Sector Composition

Rank Sector Weight
1 Miscellaneous 25.99%
2 Energy 16.96%
3 Industrials 11.08%
4 Technology 9.6%
5 Financials 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
F icon
226
Ford
F
$55.3B
$132K 0.02%
+10,486
New +$138K
OIL
227
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
$127K 0.02%
20,367
-785
-4% -$4.72K
IMGN
228
DELISTED
Immunogen Inc
IMGN
$102K 0.02%
+33,264
New +$209K
SIRI icon
229
SiriusXM
SIRI
$9.62B
$86K 0.01%
2,182
– –
MFIC icon
230
MidCap Financial Investment
MFIC
$792M
$67K 0.01%
4,057
+7
+0.2% +$117
AEG icon
231
Aegon
AEG
$13.6B
$61K 0.01%
+20,335
New +$76.4K
ENPH icon
232
Enphase Energy
ENPH
$4.92B
$50K 0.01%
+25,000
New +$54.9K
PVCT
233
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$30K 0.01%
80,000
– –
ALSK
234
DELISTED
Alaska Communications Systems
ALSK
$17K ﹤0.01%
10,000
– –
AIVI icon
235
WisdomTree International AI Enhanced Value Fund
AIVI
$63M
– –
-5,950
Closed -$228K
ITM icon
236
VanEck Intermediate Muni ETF
ITM
$2.12B
– –
-4,343
Closed -$210K
NUV icon
237
Nuveen Municipal Value Fund
NUV
$1.89B
– –
-10,216
Closed -$107K
PANW icon
238
Palo Alto Networks
PANW
$303B
– –
-8,088
Closed -$220K
SDY icon
239
State Street SPDR S&P Dividend ETF
SDY
$22B
– –
-2,730
Closed -$218K
SNOA icon
240
Sonoma Pharmaceuticals
SNOA
$6.27M
– –
-50
Closed -$43K
UCO icon
241
ProShares Ultra Bloomberg Crude Oil
UCO
$387M
– –
-817
Closed -$91K
UL icon
242
Unilever
UL
$140B
– –
-78,953
Closed -$4.01M
VB icon
243
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
– –
-10,398
Closed -$1.16M
VEU icon
244
Vanguard FTSE All-World ex-US ETF
VEU
$70.4B
– –
-8,243
Closed -$356K
VLO icon
245
Valero Energy
VLO
$101B
– –
-3,634
Closed -$233K
VOO icon
246
Vanguard S&P 500 ETF
VOO
$1.03T
– –
-2,842
Closed -$536K
XLRN
247
DELISTED
Acceleron Pharma
XLRN
– –
-10,157
Closed -$268K
UN
248
DELISTED
Unilever NV New York Registry Shares
UN
– –
-16,328
Closed -$730K
DWRE
249
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
– –
-7,680
Closed -$300K
6 7 8 9
10

Similar funds

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

GW & Wade's Q2 2016 Portfolio in Review

As of Q2 2016, GW & Wade held 250 positions worth $583M, up 14% from $512M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

GW & Wade deployed $51.4M of net new capital in Q2 2016, opening 35 new positions and adding to 100 existing holdings. Its largest new stake was MetLife: 141,821 shares worth $5.04M.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 30% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Clorox, an estimated $6.06M trimmed.

  • GW & Wade's largest Q2 2016 buy was MetLife: 141,821 shares worth $5.04M.
  • GW & Wade added most to Amgen in Q2 2016, an estimated $6.06M increase.
  • GW & Wade's biggest Q2 2016 reduction was Clorox, cutting an estimated $6.06M.
  • GW & Wade fully exited Unilever in Q2 2016, selling an estimated $4.01M.
  • GW & Wade's ten largest holdings make up 36% of its $583M portfolio in Q2 2016.
  • GW & Wade opened 35 new positions and closed 16 in Q2 2016.
  • GW & Wade's portfolio value rose 14% quarter-over-quarter to $583M.

Based on GW & Wade's 13F filing for Q2 2016, filed 5 Aug 2016.